SCHEMBL13060289

SCHEMBL13060289

C[Si](C)(C)c1ccc(N(c2cccc(C#N)c2)c2ccc3ccc4c(N(c5ccccc5)c5ccccc5)ccc5ccc2c3c54)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNN4 O15554 1/20 0.37
KCNA5 P22460 1/20 0.37
ALDH1A1 P00352 5/20 0.34
CYP1A2 P05177 4/20 0.34
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
CYP3A4 P08684 3/20 0.34
CYP2C19 P33261 3/20 0.34
TSHR P16473 3/20 0.34
HSD17B10 Q99714 3/20 0.34
CLK4 Q9HAZ1 2/20 0.34
LMNA P02545 2/20 0.34
CYP2D6 P10635 2/20 0.34
CYP2C9 P11712 2/20 0.34
ADORA2A P29274 4/20 0.33
ADORA1 P30542 4/20 0.33
ADORA2B P29275 3/20 0.33
KDM1A O60341 1/20 0.32
MAPK1 P28482 1/20 0.32
MAPT P10636 4/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13060519 1.00 KCNN4 (0.37) KCNN4KCNA5ALDH1A1CYP1A2MEN1
SCHEMBL13004407 1.00 KCNN4 (0.37) KCNN4KCNA5ALDH1A1CYP1A2MEN1
SCHEMBL13060517 1.00 KCNN4 (0.37) KCNN4KCNA5ALDH1A1CYP1A2MEN1
SCHEMBL13060562 0.98 KCNN4 (0.33) KCNN4KCNA5ALDH1A1CYP1A2MEN1
SCHEMBL13060563 0.98 KCNN4 (0.33) KCNN4KCNA5ALDH1A1CYP1A2MEN1
SCHEMBL13060518 0.98 KCNN4 (0.33) KCNN4KCNA5ALDH1A1CYP1A2MEN1
SCHEMBL13060317 0.95 SLC6A4 (0.32) KCNN4KCNA5ALDH1A1CYP1A2MEN1
SCHEMBL13004391 0.94 KDM4C (0.32) KCNN4KCNA5PGRKDM4C
SCHEMBL13060521 0.93 KCNN4 (0.37) KCNN4KCNA5ALDH1A1CYP1A2MEN1
SCHEMBL13060301 0.93 KCNN4 (0.37) KCNN4KCNA5ALDH1A1CYP1A2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7846558-B2 Blue light emitting compound and organic electroluminescent device using the same SFC CO., LTD. (KR) 2010-12-07 US disclosed
US-20080203905-A1 Blue light emitting compound and organic electroluminescent device using the same SFC CO., LTD. (KR) 2008-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080203905-A1 Blue light emitting compound and organic electroluminescent device using the same TYR, CYBA, CRY2 KCNN4 604/4885KCNA5 186/4885ALDH1A1 182/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.